susoctocog alfa 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
blood factor VIII 5069 1339940-90-7

Description:

MoleculeDescription

Synonyms:

  • susoctocog alfa
  • obizur
a recombinant B-domain deleted porcine sequence Factor VIII, binds to von Willebrand factor
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Nov. 11, 2015 EMA Baxalta Innovations GmbH

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC B02BD14 BLOOD AND BLOOD FORMING ORGANS
ANTIHEMORRHAGICS
VITAMIN K AND OTHER HEMOSTATICS
Blood coagulation factors

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Acquired factor VIII deficiency disease indication 14230004




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
6892UQT2GK UNII
4019616 VANDF
4029702 VANDF
C3859426 UMLSCUI
DB11606 DRUGBANK_ID
9822 INN_ID
1592899 RXNORM
233325 MMSL
d00525 MMSL
d05974 MMSL
002035 NDDF
003830 NDDF
015739 NDDF
278910002 SNOMEDCT_US
416523005 SNOMEDCT_US
725746009 SNOMEDCT_US
C0015506 UMLSCUI
104815 PUBCHEM_CID

Pharmaceutical products:

None